CLINICAL_TRIALS
trial_result
· 2026-02-02
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of AST-001 in children with Autism Spectrum Disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astrogen, Inc. | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED